NPS Pharma CEO: Market Recognizing Pipeline Potential
Francois Nader, CEO of NPS Pharmaceuticals, says the market is realizing the potential of its Gattex and Natpara drugs.
Disclosure: TheStreet's editorial policy prohibits staff editors and reporters from holding positions in any individual stocks.
Scroll to Continue
